{"query": "Cipla Q2 Results Live: Profit Rises by 15.18% YoY", "similar": [{"title": "Cipla stock corrects after a disappointing March quarter", "date": "2021-05-17 22:19:07.000", "impact": "+3.56%"}, {"title": "BRIEF-India’s Cipla March-Quarter Consol Net Profit Jumps", "date": "2021-05-14 05:30:00.000", "impact": "+1.29%"}, {"title": "BS Awards for Corporate Excellence 2021: Samina Hamied lauds team effort", "date": "2022-03-29 15:28:00.000", "impact": "-0.70%"}]}
{"query": "Cipla faces challenges of slow growth, drug launch; analysts slash target", "similar": [{"title": "Cipla Betting Big On Digitisation And Emerging Segments", "date": "2022-08-07 13:51:11.000", "impact": "+4.46%"}, {"title": "Cipla looks to expand its covid-19 portfolio over next two months", "date": "2021-05-16 22:55:30.000", "impact": "+1.29%"}, {"title": "Most brokerages bullish on Cipla; cite US, local market growth potential", "date": "2022-01-29 10:11:00.000", "impact": "+6.97%"}]}
{"query": "Cipla stock in focus after Q2 PAT beats estimates. Should you buy, sell or hold?", "similar": [{"title": "As Cipla’s stock runs up, deal pricing key for Blackstone", "date": "2023-08-09 11:30:19.000", "impact": "+4.62%"}, {"title": "Cipla’s Promising Growth Prospects in India and the US", "date": "2023-05-06 20:56:14.000", "impact": "+1.58%"}, {"title": "Why Cipla Is Jefferies’ ‘Top Pick’ Among India Pharma Stocks", "date": "2022-09-16 13:14:29.000", "impact": "-1.40%"}]}
{"query": "Q2FY25: Cipla reports 15.2% rise in net profit to Rs 1303 crore; Slow growth reported in acute category", "similar": [{"title": "BRIEF-India’s Cipla March-Quarter Consol Net Profit Jumps", "date": "2021-05-14 05:30:00.000", "impact": "+1.29%"}, {"title": "Coal India’s net falls 21% to Rs 3,084 crore in December quarter", "date": "2021-02-11 19:09:00.000", "impact": "-0.40%"}, {"title": "Cipla gains on licensing agreement with Eli Lilly for Covid drug baricitinib", "date": "2021-05-10 10:26:00.000", "impact": "+1.29%"}]}
{"query": "Cipla shares jumped 10% today after THIS update from USFDA. Details here", "similar": [{"title": "Most brokerages bullish on Cipla; cite US, local market growth potential", "date": "2022-01-29 10:11:00.000", "impact": "+6.97%"}, {"title": "Why Cipla Is Jefferies’ ‘Top Pick’ Among India Pharma Stocks", "date": "2022-09-16 13:14:29.000", "impact": "-1.40%"}, {"title": "Cipla, Dr Reddy’s Labs: Tech charts show up to 11% rally in pharma stocks", "date": "2021-06-30 12:28:00.000", "impact": "+1.79%"}]}
{"query": "Cipla share price falls the most among Nifty companies - Hindustan Times", "similar": [{"title": "Most brokerages bullish on Cipla; cite US, local market growth potential", "date": "2022-01-29 10:11:00.000", "impact": "+6.97%"}, {"title": "Cipla corrects over 8% in five sessions", "date": "2021-12-07 12:54:00.000", "impact": "-2.32%"}, {"title": "BRIEF-India’s Cipla March-Quarter Consol Net Profit Jumps", "date": "2021-05-14 05:30:00.000", "impact": "+1.29%"}]}
{"query": "Multiple near-term challenges may hijack Cipla's growth trajectory", "similar": [{"title": "Cipla: M&A Opportunity Could Be Near-term Trigger", "date": "2021-08-06 11:38:07.000", "impact": "-1.83%"}, {"title": "Cipla Betting Big On Digitisation And Emerging Segments", "date": "2022-08-07 13:51:11.000", "impact": "+4.46%"}, {"title": "Cipla eyes acquisitions in India, US after Covid-led windfall", "date": "2021-10-01 14:56:00.000", "impact": "+2.20%"}]}
{"query": "Cipla shares jump 10% after USFDA paves the way for an important drug launch", "similar": [{"title": "Why Cipla Is Jefferies’ ‘Top Pick’ Among India Pharma Stocks", "date": "2022-09-16 13:14:29.000", "impact": "-1.40%"}, {"title": "Most brokerages bullish on Cipla; cite US, local market growth potential", "date": "2022-01-29 10:11:00.000", "impact": "+6.97%"}, {"title": "Cipla looks to expand its covid-19 portfolio over next two months", "date": "2021-05-16 22:55:30.000", "impact": "+1.29%"}]}
{"query": "Pharma Major Cipla Declares 15.2% YoY Surge In Q2 Net Profit, Shares In Red; Buy?", "similar": [{"title": "Board of large-cap pharma company Cipla fixes record date for 250% dividend", "date": "2022-07-27 20:41:37.000", "impact": "+0.14%"}, {"title": "Why Cipla Is Jefferies’ ‘Top Pick’ Among India Pharma Stocks", "date": "2022-09-16 13:14:29.000", "impact": "-1.40%"}, {"title": "Pharma stocks gain as DGCI approves emergency use of COVID pill Molnupiravir", "date": "2021-12-29 10:23:00.000", "impact": "+3.42%"}]}
{"query": "Cipla Q2 results: Net profit rises 15% to Rs 1,303 crore, revenue up 5.6%", "similar": [{"title": "Coal India’s net falls 21% to Rs 3,084 crore in December quarter", "date": "2021-02-11 19:09:00.000", "impact": "-0.40%"}, {"title": "BRIEF-India’s Cipla March-Quarter Consol Net Profit Jumps", "date": "2021-05-14 05:30:00.000", "impact": "+1.29%"}, {"title": "HUL reports flat volume growth amid slow consumer demand recovery", "date": "2023-07-20 17:30:00.000", "impact": "+1.23%"}]}
